May 30, 2023 09:00AM

Apr 20, 2023 09:05AM

Mar 1, 2023 09:34AM

Nov 9, 2022 05:00PM

Sep 27, 2022 02:57PM

Aug 25, 2022 01:30PM

Aug 4, 2022 01:19PM Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer

Jul 22, 2022 04:26PM

Apr 27, 2022 04:11PM

Apr 27, 2022 04:10PM

Oct 20, 2020 11:09AM

Dec 16, 2019 11:11AM

Jan 9, 2019 01:44PM

Sep 5, 2018 11:15AM Immune Therapeutics Labeled as a Pioneer in Forbes Article Discussing Booming Pet Care Industry

Jun 5, 2018 12:14PM

Jun 5, 2018 08:00AM

Nov 30, 2017 09:58AM

May 19, 2016 09:30AM

May 18, 2016 02:06PM

Apr 21, 2016 09:00AM

May 4, 2015 08:07AM Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.

1,178,426 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All